Position in RPRX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$51,729,167
-$37,611,456 QoQ
Shares Held
1,078,365
-53.4% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 27%
Shared 61%
None 12%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. RPRX ranks #25 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $51,729,167 | 1,078,365 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $89,340,623 | 2,312,128 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $74,105,284 | 2,100,490 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $68,276,559 | 1,894,992 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $53,399,995 | 1,715,387 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $42,870,445 | 1,680,535 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $31,111,868 | 1,099,748 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $20,759,964 | 787,257 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $19,664,451 | 647,496 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $17,656,501 | 628,569 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $13,620,587 | 501,864 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $12,374,292 | 402,547 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $14,050,221 | 389,959 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,847,040 | 325,077 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $13,477,935 | 335,439 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,316,036 | 292,960 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,101,301 | 284,941 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,173,509 | 230,201 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $5,801,012 | 160,515 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $374,894 | 9,146 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $411,816 | 9,441 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||